| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |